Tert-butyl (2S,6R)-2-[[(7-fluoro-2-methylindazol-5-yl)amino]methyl]-6-methylpiperazine-1-carboxylate
C19H28FN5O2 — CID 176566663
Data last refreshed: (MolForge compound catalog, from PubChem)
About Tert-butyl (2S,6R)-2-[[(7-fluoro-2-methylindazol-5-yl)amino]methyl]-6-methylpiperazine-1-carboxylate
Tert-butyl (2S,6R)-2-[[(7-fluoro-2-methylindazol-5-yl)amino]methyl]-6-methylpiperazine-1-carboxylate (PubChem CID 176566663) has the molecular formula C19H28FN5O2 and a molecular weight of 377.46 g/mol. Its IUPAC name is tert-butyl (2S,6R)-2-[[(7-fluoro-2-methylindazol-5-yl)amino]methyl]-6-methylpiperazine-1-carboxylate.
Molecular Properties
| Compound Name | Tert-butyl (2S,6R)-2-[[(7-fluoro-2-methylindazol-5-yl)amino]methyl]-6-methylpiperazine-1-carboxylate |
|---|---|
| PubChem CID | 176566663 |
| Molecular Formula | C19H28FN5O2 |
| Molecular Weight | 377.46 g/mol |
| Exact Mass | 377.22 |
| IUPAC Name | tert-butyl (2S,6R)-2-[[(7-fluoro-2-methylindazol-5-yl)amino]methyl]-6-methylpiperazine-1-carboxylate |
| SMILES | C[C@@H]1CNC[C@@H](CNc2cc(F)c3nn(C)cc3c2)N1C(=O)OC(C)(C)C |
| InChI | InChI=1S/C19H28FN5O2/c1-12-8-21-9-15(25(12)18(26)27-19(2,3)4)10-22-14-6-13-11-24(5)23-17(13)16(20)7-14/h6-7,11-12,15,21-22H,8-10H2,1-5H3/t12-,15+/m1/s1 |
| InChIKey | REGDCQRJLATUTP-DOMZBBRYSA-N |
| XLogP | 2.72 |
| TPSA | 71.42 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 27 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 377.46 |
| LogP ≤ 5 | 2.72 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 176566663 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.